NCT01827618View on ClinicalTrials.gov

Neoadjuvant Rapamycin in Patients Undergoing Radical Cystectomy

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

April 30, 2014

Study Completion Date

April 30, 2014

Conditions
Invasive Bladder Cancer Stage II
Interventions
DRUG

Rapamycin

Trial Locations (1)

78229

UT Health Science Center San Antonio, San Antonio

All Listed Sponsors
lead

The University of Texas Health Science Center at San Antonio

OTHER

NCT01827618 - Neoadjuvant Rapamycin in Patients Undergoing Radical Cystectomy | Biotech Hunter | Biotech Hunter